v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   102,088,783    
Beginning balance at Dec. 31, 2024 $ 357,030 $ 102 $ 833,129 $ (476,201)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 16,365   16,365  
Issuance of common stock upon restricted stock unit vesting (in shares)   697,506    
Issuance of common stock upon restricted stock unit vesting 0 $ 1 (1)  
Exercised stock options (in shares)   233,687    
Exercised stock options 1,523   1,523  
Capped calls (33,879)   (33,879)  
Share-based compensation replacement awards related to merger consideration and attributable to pre-combination services 821   821  
Net loss (7,816)     (7,816)
Ending balance (in shares) at Mar. 31, 2025   103,019,976    
Ending balance at Mar. 31, 2025 $ 334,044 $ 103 817,958 (484,017)
Beginning balance (in shares) at Dec. 31, 2025 106,101,875 106,101,875    
Beginning balance at Dec. 31, 2025 $ 362,049 $ 106 885,796 (523,853)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 17,594   17,594  
Issuance of common stock upon restricted stock unit vesting (in shares)   805,506    
Issuance of common stock upon restricted stock unit vesting   $ 1 (1)  
Exercised stock options (in shares)   111,793    
Exercised stock options 974   974  
Net loss $ (9,963)     (9,963)
Ending balance (in shares) at Mar. 31, 2026 107,019,174 107,019,174    
Ending balance at Mar. 31, 2026 $ 370,654 $ 107 $ 904,363 $ (533,816)